Ad
related to: chemours stock
Search results
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 years agoChemours (CC) closed at $31.44 in the latest trading session, marking a -0.47% move from the prior...
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
Zacks via Yahoo Finance· 2 years agoWhile Chemours (CC) is exposed to supply-chain issues and higher input costs, it gains on healthy...
Is Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
Zacks via Yahoo Finance· 2 years agoThe Basic Materials group has plenty of great stocks, but investors should always be looking for...
Chemours (CC) Stock Jumps 7.4%: Will It Continue to Soar?
Zacks via Yahoo Finance· 2 years agoChemours (CC) witnessed a jump in share price last session on above-average trading volume. The...
Why Chemours Stock Soared Today
Motley Fool via Yahoo Finance· 3 months agoShares of Chemours (NYSE: CC) rallied 16.8% today after the chemical company concluded an internal review that's loomed over the business for the past...
Chemours (CC) Lags Q3 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 8 months agoChemours (CC) delivered earnings and revenue surprises of -16.88% and 3.63%, respectively, for the quarter ended September 2023. Do the numbers hold...
Chemours (CC) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 months agoImage source: The Motley Fool. Chemours (NYSE: CC) Q4 2023 Earnings Call Mar 28, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Why Chemours Stock Is Plunging Today
Motley Fool via Yahoo Finance· 2 months agoChemours (NYSE: CC) surpassed top- and bottom-line quarterly expectations, but investors are more focused on the drama going on behind the scenes. Shares...
Chemours (CC) Stock Up 25% in 6 Months: What's Driving It?
Zacks via Yahoo Finance· 2 years agoThe Chemours Company’s CC shares have popped 25% over the past six months. The company has also...
Chemours (CC) to Post Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoChemours' (CC) second-quarter performance is likely to reflect the increasing adoption of Opteon...